Impact of the Coronavirus (COVID-19) on Patients With Cancer
NCT ID: NCT04330521
Last Updated: 2024-11-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2020-04-08
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Patient Experience During Treatment for Cancer
NCT01553825
The Psychological Impact of COVID-19 on Patients with Solid Malignancies: a Single-Institution Survey Study
NCT05359718
COvid-19 aNd TechNology - thE Impact on Clinical Trial Patients
NCT04852809
Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic
NCT04421625
Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
NCT04447222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who opt in to complete the survey.
3. Patients must have the capacity to verbally consent for the interview.
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manali Indravadan Patel
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Impact of the novel Coronavirus (COVID-19) on Patients with Cancer Qualtrics Survey
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
55596
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.